EFI
SLN

EHP Funds Inc’s Silence Therapeutics SLN Stock Holding History

EHP Funds Inc’s Portfolio SLN Stock Details SLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,673
Closed -$55.4K – 87
2025
Q3 		$55.4K Buy
+10,673
New +$59.3K 0.05% 96

Other funds holding SLN

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

EHP Funds Inc's SLN Position: Q4 2025 in Review

EHP Funds Inc sold out of Silence Therapeutics (SLN) in Q4 2025, closing a stake of 10,673 shares — an estimated $55.4K sold.

EHP Funds Inc first reported a position in SLN in Q3 2025 and held it in 1 quarter. The position peaked at $55.4K in Q3 2025. 58 funds tracked by Wall St. Rank hold SLN as of Q4 2025.

  • EHP Funds Inc reported no remaining Silence Therapeutics position as of Q4 2025 after selling out during the quarter.
  • EHP Funds Inc sold 10,673 Silence Therapeutics shares in Q4 2025, an estimated $55.4K.
  • EHP Funds Inc first reported a position in Silence Therapeutics in Q3 2025 and held it in 1 quarter.
  • EHP Funds Inc's Silence Therapeutics position peaked at $55.4K in Q3 2025.
  • 58 funds tracked by Wall St. Rank held Silence Therapeutics as of Q4 2025.

Based on EHP Funds Inc's 13F filing for Q4 2025, filed 12 Feb 2026.